NVST — Envista Holdings Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapSuper Stock

Annual income statement for Envista Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,929	2,509	2,569	2,567	2,511
Cost of Revenue
Gross Profit	1,073	1,473	1,488	1,451	1,392
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses	1,886	2,203	2,250	2,535	3,549
Operating Profit	43.5	306	319	31.5	-1,038
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-20	255	284	-54.9	-1,085
Provision for Income Taxes
Net Income After Taxes	42.5	264	238	-100	-1,119
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	33.3	341	243	-100	-1,119
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	33.3	341	243	-100	-1,119
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.699	1.83	1.54	0.542	-1.99